Hester Biosciences approves raising up to Rs 150cr via QIP, preferential allotment

The board also approved reappointment of Rajiv Gandhi, CEO and Managing Director of the company, for a period of three years from April 1, 2020 to March 31, 2023, subject to approval of members through postal ballot process.

from Moneycontrol Business News https://ift.tt/2S6c6dE